Maynard Um
-
-
-
-
-
-
-
Tempest details strategy for advancing CAR-T therapy pipeline
-
-
-
-
-
-
-
Tempest Therapeutics, Inc. (TPST) Misses Q2 EPS by 179c
-
-
-
-
-
-
-
H.C. Wainwright Downgrades Tempest Therapeutics (TPST) to Neutral
-
-
-
-
-
-
-
Tempest Therapeutics, Inc. (TPST) Misses Q3 EPS by 5c
-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat
-
411,279 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

